Page last updated: 2024-11-05

hexachloroiridic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hexachloroiridic acid, also known as iridium(IV) chloride, is a coordination compound with the formula [IrCl6]H2. It is a dark red solid that is soluble in water and alcohols. It is used as a catalyst in organic reactions and as a starting material for the synthesis of other iridium compounds. The compound is typically synthesized by reacting iridium metal with chlorine gas in the presence of hydrochloric acid. The reaction is typically carried out at high temperatures and pressures. Hexachloroiridic acid is a strong oxidizing agent and is used in a variety of applications, including the synthesis of organic compounds, the electroplating of iridium, and the production of iridium catalysts. The compound is also used in analytical chemistry to determine the concentration of iridium in solutions. Its importance lies in its use as a catalyst in various reactions, including the oxidation of organic compounds and the reduction of nitro groups. The compound is also used in the synthesis of other iridium compounds, such as iridium complexes and iridium nanoparticles. The compound is studied because it has a variety of interesting properties, including its catalytic activity, its ability to form complexes with organic molecules, and its ability to be used in the synthesis of other iridium compounds.'

hexachloroiridic acid: inhibitor of DNA synthesis; K2IrCl6 as oxidizing agent; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID28153
MeSH IDM0056917

Synonyms (12)

Synonym
chloriridic acid
dihydrogen hexachloroiridate(2-)
chloroiridic acid (h2ircl6)
hydrogen hexachloroiridate(4+)
einecs 241-012-8
iridate(2-), hexachloro-, dihydrogen
hexachloroiridic acid
iridate(2-), hexachloro-, hydrogen (1:2), (oc-6-11)-
AKOS026669550
DTXSID40274844
CS-0085628
hexachloroiridium(2-);hydron
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's3 (20.00)18.2507
2000's3 (20.00)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.96 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]